Clinique and Mount Sinai partner to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center

Clinique and Icahn School of Medicine at Mount Sinai today announced a philanthropic partnership to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center.

Moonlake’s less-than-transparent data disclosures produced a cash windfall. Risks remain

For two days starting on Sunday, Moonlake Immunotherapeutics happily crunched numbers and shared results from a mid-stage clinical trial that depicted its experimental antibody in

June 28, 2023

Cautious Return-to-Play Appears Safe for Athletes With Heart Conditions

For elite-level athletes diagnosed with a genetic heart disease, the first available outcomes data on a return-to-play (RTP) protocol favored the approach, comprising shared decision-making

August 15, 2023

Telix announces Canada approval for Illuccix label expansion

Illuccix is used for PET imaging to detect PSMA-positive lesions in male prostate cancer patients. Credit: Korawat photo shoot/Shutterstock. Health Canada has expanded the approved

October 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.